How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
147 articles on this topic
-
Semax Half-Life: The Honest Answer Is Unknown
There is no measured Semax half-life in humans. Rat studies show that intact Semax reaches the brain within minutes and breaks down quickly, but they do not supply a reliable human clock.
-
Semaglutide Pronunciation: How to Say It
Semaglutide is pronounced sem-a-GLOO-tide. The middle is easier once you know where the stress goes and why several related medicine names share the same ending.
-
Kisspeptin Supplement: A Capsule Isn't the Peptide
A capsule sold as a kisspeptin supplement does not deliver the peptide used in the hormone and fertility studies people usually quote. Those studies used a vein or an injection under the skin, not an ordinary pill.
-
PT-141 Half-Life Is About 2.7 Hours
The number is short, but it is not a stopwatch for how long someone feels an effect. Here is what the label's timing, clearance range, and safety limits actually mean.
-
Tesamorelin vs Tirzepatide: Which Fits Which Goal?
Tesamorelin and tirzepatide can both change fat-related measures, but they answer different clinical questions. One has narrow evidence for deep abdominal fat in adults with HIV lipodystrophy; the other was studied for total body weight.
-
MK-677 vs Sermorelin: Why the Route Matters
MK-677 is an unapproved oral ghrelin mimic, while sermorelin is a prescribed GHRH peptide. Both can raise growth-hormone signals, but only one comes with a provider, pharmacy record and follow-up.
-
MOTS-c Before and After: What Research Shows
MOTS-c before and after photos are not clinical evidence. Human research has measured exercise and metabolic markers, but no completed study has published visible results from giving native MOTS-c—the exact peptide, not an altered analogue—to people.
-
Semaglutide Type 1 Diabetes: Guidance Has Limits
New 2026 guidance treats GLP-1 therapy as a possible obesity tool for some adults with type 1 diabetes, not as a replacement for insulin. The evidence is promising but small, and semaglutide is not approved to treat type 1 diabetes.
-
Sermorelin Half-Life: About 11 to 12 Minutes
Sermorelin leaves the bloodstream in minutes, but the growth-hormone pulse it starts can last for hours. Those are two different clocks, and neither is a personal dosing or drug-testing deadline.
-
Tirzepatide Meal Plan: Small Meals, Protein First
A useful tirzepatide meal plan is smaller and steadier: protein first, produce and fiber as tolerated, and fluids between meals. It should bend around appetite and side effects, not force a calorie target.
-
Does Tesamorelin Build Muscle? What Trials Show
Tesamorelin raised lean mass modestly in trials of adults with HIV-related lipodystrophy, but that is not proof of bigger or stronger muscles. It has not been shown to build muscle in healthy lifters.
-
Oral TB-500: Why Capsules Lack Human Evidence
There is no human evidence that a TB-500 capsule delivers intact peptide into the bloodstream. The published TB-500 and thymosin beta-4 work used injected or topical routes, so a capsule label cannot prove absorption or an effect.
-
Semaglutide Before and After: An Honest Timeline
The first month is usually an adjustment period, month six is still part of the active curve, and a plateau often comes much later. Photos cannot show the treatment, timing, or follow-up behind a change.
-
Semax Selank Nasal Spray: What the Route Changes
A Semax Selank nasal spray puts both peptides in one intranasal liquid, but there is no universal recipe. The route, concentration, pump, and prescription all matter—and Promise's current blend is listed as an injectable vial, not a nasal spray.
-
Tesamorelin Before and After: The Study Timeline
Expect an early lab signal, not a one-month change in the mirror. The strongest trials measured deep abdominal fat at 26 and 52 weeks, all in adults with HIV-associated lipodystrophy.
-
DSIP Nasal Spray: What the Human Research Says
A DSIP nasal spray appears in one small human experiment, but no published human nasal PK or sleep trial validates the format. Promise currently lists DSIP as an injection, not a spray.
-
Is Tesamorelin a Steroid? No—It's a GHRH Peptide
Tesamorelin is a peptide signal, not an anabolic steroid or growth hormone itself. It prompts the pituitary to release growth hormone, but sport rules still prohibit it.
-
Kisspeptin vs PT-141: They Work Differently
Kisspeptin and PT-141 both enter libido conversations, but they act on different systems and do not share the same evidence. PT-141 has larger trials and an approved branded product; kisspeptin's human data are smaller and earlier.
-
Orforglipron Is Approved: What Foundayo Changes
Orforglipron is now sold as Foundayo, a once-daily GLP-1 pill for weight management. It removes the fasting rules of oral semaglutide, but it does not replace every reason someone may choose an injection.
-
Sermorelin Before and After: A Research Timeline
The research shows hormone changes within weeks, not a predictable visible transformation. Here is what small adult studies measured at two, six, and 16 weeks.
Page 2 of 8 · 147 articles